Orlistat

Female Infertility

Yale UniversitySmall moleculePhase 3Dormant

B

62/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 49/ 100
Competitive Position: 89/ 100

Competitive context

5 Active assets in the Female Infertility cohort.

Asset / Sponsor	Phase	Rating
Metformin Peking University Third Hospital	Phase 4	BBB
Letrozole Peking University Third Hospital	Phase 4	BBB
Liraglutide Mỹ Đức Hospital	Phase 4	BB
Follitropin Beta Universitair Ziekenhuis Brussel	Phase 3	B
Corifollitropin Alfa Universitair Ziekenhuis Brussel	Phase 3	B

View all 14 →

Same molecule, other indications

Orlistat is also rated in:

type 2 diabetes mellitusActive

BBB

Indicative · Phase 4

73 / 100

polycystic ovary syndromeActive

BB

Indicative · Phase 4

70 / 100

binge eating disorderDormant

BB

Indicative · Phase 4

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.